Variable | Total | Critically morbidly obese | Noncritically obese | Critically nonobese | ||
---|---|---|---|---|---|---|
Dose (mg) | 100 | 150 | 100 | 150 | 100 | |
n | 31 | 7 | 4 | 7 | 3 | 10 |
Age (years), median (range) | 58 (27–85) | 45 (27–73) | 53.5 (44–63) | 58 (48–85) | 58 (43–73) | 72 (43–85) |
% Females | 71.0 | 100 | 50.0 | 85.7 | 100 | 40 |
BMIa (kg/m2), median (range) | 34.7 (19.6–60.0) | 44.2 (40.3–51.7) | 52.8 (47.4–60.0) | 27.7 (25.2–34.7) | 35.5 (34.7–52.4) | 23.1 (19.6–38.5) |
Weight (kg), median (range) | 95 (44–193) | 113 (95–121) | 157.5 (142–170) | 84.1 (62–105) | 105 (105–193) | 65 (44.0–92.5) |
Creatinine (mg/dl), median (range) | 1.0 (0.4–3.9) | 0.7 (0.6–1.5) | 1.3 (0.6–1.7) | 1.1 (0.7–1.4) | 0.8 (0.7–1.5) | 1.0 (0.4–3.0) |
CrCla (ml/min/1.73m2) | 93.4 ± 51.4 | 133.1 ± 44.9 | 112.5 ± 53.2 | 62.7 ± 38.4 | 105.4 ± 63.9 | 75.9 ± 46.1 |
Albumin (g/dl), median (range) | 3 (1.2–4.0) | 2.7 (1.9–3.5) | 3.1 (2.4–4) | 3.5 (2.6–3.9) | 3.6 (3.4–3.7) | 2.5 (1.2–3.3) |
Candida score, median (range) | 3 (2–4)b | 3 (2–4) | 3.5 (3–4) | DTc | DTd | 3 (2–4) |
SOFAa score, median (range) | 6 (0–12) | 6 (2–8) | 7 (5–10) | 5 (2–10) | 6 (5–7) | 4.5 (0–12) |
SAPSa II, median (range) | 34 (9–57) | 40 (8–57) | 34.5 (25–45) | 47 (9–53) | 41 (18–44) | 26 (11–42) |